模拟研究评估分析误差对新生儿血糖测量分类的影响:基于加拿大儿科学会行动阈值
本研究基于新生儿重症监护病房(NICU)的23 749例血糖数据,通过有限混合模型生成100 000个真实血糖值的模拟数据集,并加入偏倚和变异系数(CV)以模拟测量值,采用蒙特卡洛模拟评估在加拿大儿科学会(CPS)行动阈值(32、36、47 mg/dL)处的误分类率。结果显示,在CV 5%且偏倚+10 mg/dL时,32和47 mg/dL阈值处因偏倚导致的假性血糖正常误分类率为0.8%–5%;在CV 5%且偏倚-10 mg/dL时,32和47 mg/dL阈值处因偏倚和变异共同导致的假性低血糖误分类率为3%–12.5%。作者结论认为,使用CPS行动阈值时,该模拟模型可预测在特定偏倚和变异值下NICU血糖仪结果导致不适当临床措施(遗漏治疗或过度治疗)的风险比例。
要点
- 在CV 5%且偏倚+10 mg/dL时,32和47 mg/dL阈值处因偏倚导致的假性血糖正常误分类率为0.8%–5%。
- 在CV 5%且偏倚-10 mg/dL时,32和47 mg/dL阈值处因偏倚和变异共同导致的假性低血糖误分类率为3%–12.5%。
- 评估的偏倚范围为-20至+20 mg/dL,CV范围为0%至20%,在32、36、47 mg/dL阈值处预测误分类率。
- 模拟数据集来自NICU血糖数据(N=23 749)通过有限混合模型分析生成100 000个真实血糖值。
- 使用CPS行动阈值时,模拟模型可预测在特定偏倚和变异值下NICU血糖仪结果导致不适当临床措施的风险比例。
适用人群与场景
- 有新生儿低血糖风险的婴儿,其血糖监测使用CPS指南推荐的筛查和即时管理算法。
诊断标准与关键阈值
- CPS行动阈值:32、36、47 mg/dL,提供时间依赖性血糖浓度行动阈值。
研究设计与关键结果
- 研究类型:模拟研究,基于NICU血糖数据(N=23 749)通过有限混合模型分析生成100 000个真实血糖值的模拟数据集。
- 干预与对照:向真实血糖值加入偏倚(-20至+20 mg/dL)和变异系数(0%至20%)以创建测量值,采用蒙特卡洛模拟评估在CPS行动阈值(32、36、47 mg/dL)处的误分类率。
- 主要终点结果:在CV 5%且偏倚+10 mg/dL时,32和47 mg/dL阈值处因偏倚导致的假性血糖正常误分类率为0.8%–5%;在CV 5%且偏倚-10 mg/dL时,32和47 mg/dL阈值处因偏倚和变异共同导致的假性低血糖误分类率为3%–12.5%。
证据类型、等级与局限
- 证据类型:模拟研究,基于NICU血糖数据的有限混合模型分析和蒙特卡洛模拟。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为,使用CPS行动阈值时,该模拟模型可预测在特定偏倚和变异值下NICU血糖仪结果导致不适当临床措施(遗漏治疗或过度治疗)的风险比例。
指南或共识出处
- 加拿大儿科学会(CPS)立场声明:新生儿低血糖筛查和即时管理算法,提供时间依赖性血糖浓度行动阈值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The Canadian Pediatric Society (CPS) has endorsed an algorithm for the screening and immediate management of babies at risk of neonatal hypoglycemia that provides time-dependent glucose concentration action thresholds. The objective of this study was to evaluate the impact of glucose analytic error (bias and imprecision) on the misclassification of glucose meter results from a neonatal intensive care unit (NICU) using the CPS guidelines.
METHODS: A simulation dataset of true glucose values (N = 100 000) was derived by finite mixture model analysis of NICU glucose data (N = 23 749). Bias and imprecision were added to create measured glucose values. The percentages of measured glucose values that were misclassified at CPS action thresholds were determined by Monte Carlo simulation.
RESULTS: Measurement biases ranging from -20 to +20 mg/dL combined with coefficients of variation 0% to 20% were evaluated to predict misclassification rates at 32, 36, and 47 mg/dL. The models demonstrated low risk of false normoglycemia-at 5% CV and +10 mg/dL bias: 0.8% to 5% misclassification at the 32 and 47 mg/dL thresholds due to bias. The models demonstrated risk of false hypoglycemia-at 5% CV and -10 mg/dL bias: 3% to 12.5% misclassification at 32 and 47 mg/dL thresholds due to both bias and imprecision.
CONCLUSION: Using CPS action thresholds, the simulation model predicted the proportion of neonates at risk of inappropriate clinical action-both of omission or "failure to treat" and commission or "overtreatment" in response to NICU glucose meter results at specific bias and imprecision values.
参考来源
- Inman M, Parker K, Strueby L, et al. A Simulation Study to Assess the Effect of Analytic Error on Neonatal Glucose Measurements Using the Canadian Pediatric Society Position Statement Action Thresholds. J Diabetes Sci Technol. 2019. PMID: 31694397. doi:10.1177/1932296819884923
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。